Lantern Pharma Inc. has filed 248 documents with the SEC available on Filing Fan. Browse annual reports (10-K), quarterly reports (10-Q), earnings releases (8-K), proxy statements, and more on Filing Fan. Filing Fan provides income statements, balance sheets, cash flow statements, and segment data parsed directly from EDGAR filings. All financial data is sourced from publicly available SEC regulatory filings.
| Form | Date | Description |
|---|---|---|
| SC 13G/A | 2026-07-23 | Beneficial Ownership Report (Passive, Amended) |
| S-1 | 2026-06-12 | Registration Statement |
| 8-K | 2026-06-02 | Regulation FD Disclosure; Financial Statements and Exhibits |
| D | 2026-05-21 | D |
| SC 13D/A | 2026-05-15 | Beneficial Ownership Report (Amended) |
| 8-K | 2026-05-15 | Results of Operations and Financial Condition; Financial Statements and Exhibits |
| 10-Q | 2026-05-15 | Quarterly Report |
| 4 | 2026-05-14 | Statement of Changes in Beneficial Ownership |
| 8-K | 2026-05-14 | Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities |
| 4 | 2026-05-14 | Statement of Changes in Beneficial Ownership |